Therapeutic Potential of microRNA Modulation in Pulmonary Arterial Hypertension

Area of Science:

• Molecular Biology
• Cardiovascular Research
• Gene Regulation

Background:

• MicroRNAs (miRNAs) are key regulators of gene expression implicated in various diseases, including cancer and cardiovascular conditions.
• Pulmonary arterial hypertension (PAH) is a vascular disease characterized by increased pulmonary resistance and vessel occlusion.
• PAH shares common pathways with cancer, involving aberrant proliferation and survival of pulmonary arterial smooth muscle cells (PASMCs).

Purpose of the Study:

• To review the current understanding of microRNA involvement in pulmonary arterial hypertension (PAH).
• To highlight recent findings on specific microRNAs and their roles in PAH pathogenesis.
• To discuss future directions and therapeutic potential of microRNAs in PAH.

Main Methods:

• Literature review of recent studies on microRNAs in PAH.
• Analysis of identified microRNAs and their association with PAH pathways.
• Synthesis of current knowledge and future perspectives.

Main Results:

• Specific microRNAs, including miR-204 and miR-206, are implicated in PASMC proliferation.
• Other miRNAs like miR-145, miR-21, and the miR17/92 cluster are linked to the disrupted BMPR2 pathway in PAH.
• The role of microRNAs in PAH is a rapidly expanding and significant area of research.

Conclusions:

• MicroRNAs play a critical role in the molecular mechanisms underlying PAH.
• Further research is needed to translate microRNA knowledge into effective clinical therapies for PAH.
• MicroRNA-based therapies hold promise but require further development and validation for clinical application.